BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 8259235)

  • 1. [Age-related changes in the renin-angiotensin-aldosterone system and the sympathetic nervous system in patients with essential hypertension].
    Nami R; Martinelli M; Panza F; Pavese G; Carletti F; Buracchi P; Lucani B; Pazzaglia A; Saia F; Gennari C
    Minerva Cardioangiol; 1993 Sep; 41(9):387-95. PubMed ID: 8259235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The renin-angiotensin system and the sympathetic nervous system in essential hypertension].
    Vincent M; Milon H; Revol T; Annat G; Froment A; Sassard J; Cier JF
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():91-4. PubMed ID: 6810836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension.
    Iimura O; Kikuchi K; Shimamoto K; Nozawa A; Hasegawa R; Homma C; Komura H; Kobayakawa H
    Arzneimittelforschung; 1989 Jun; 39(6):710-4. PubMed ID: 2775339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of genetic factors on selected indicators of the activity of the sympathoadrenal system and the renin-angiotensin-aldosterone system in twins.
    Jedrusik P; Januszewicz A; Busjahn A; Wocial B; Ignatowska-Switalska H; Strelau J; C Luft F; Januszewicz W
    Kardiol Pol; 2004 Nov; 61(11):423-9; discussion 430. PubMed ID: 15883590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives].
    Vetter H; Zumkley H; Glänzer K; Witassek F; Wollnik S; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(50):1938-41. PubMed ID: 7010579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis.
    Ruano M; Silvestre V; Castro R; García-Lescún MC; Rodríguez A; Marco A; García-Blanch G
    Obes Surg; 2005 May; 15(5):670-6. PubMed ID: 15946459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of epinephrine in the development of essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Contorno A; Carone MB; Fulantelli MA
    J Clin Hypertens; 1987 Dec; 3(4):670-80. PubMed ID: 3453396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)].
    Mantero F; Perini A; Armanini D; Gion M; Opocher G; Boscaro M
    G Ital Cardiol; 1976; 6(7):1246-53. PubMed ID: 1010235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renin-angiotensin-aldosterone system with regard to age].
    Zakharieva S; Ankov V
    Vutr Boles; 1982; 21(4):70-5. PubMed ID: 6755912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulatory volume in essential hypertension. Relationships with age, blood pressure, exchangeable sodium, renin, aldosterone and catecholamines.
    Beretta-Piccoli C; Weidmann P
    Miner Electrolyte Metab; 1984; 10(5):292-300. PubMed ID: 6387428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelations between plasma renin activity, aldosterone, and sympathetic nervous system activity in essential hypertension.
    Jindra A; Ripka O; Savlíková J; Peleska J; Linhartová J; Ort J
    Acta Biol Med Ger; 1978; 37(10):1543-50. PubMed ID: 752207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of coffee on blood pressure and activity renin-angiotensin- aldosterone system and catecholamines concentration in patients with essential hypertension].
    Mazurek W; Negrusz-Kawecka M
    Pol Merkur Lekarski; 1999 Oct; 7(40):159-63. PubMed ID: 10835904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension.
    Vallès Prats M; Matas Serra M; Bronsoms Artero J; Matè Benito G; Torguet Escuder P; Mauri Nicolas JM
    Kidney Int Suppl; 1996 Jun; 55():S104-6. PubMed ID: 8743525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation of atrial natriuretic peptide, the renin-angiotensin-aldosterone system and kinin system in hypertensive and normotensive youngsters with or without a family history of essential arterial hypertension].
    Musca A; Ferri C; Cammerella I; Onofri R; Tani S; Santucci A
    Medicina (Firenze); 1989; 9(2):167-72. PubMed ID: 2530412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma renin activity and plasma aldosterone in essential hypertension: effect of age and diastolic blood pressure].
    Vetter H; Alasso I; Appenheimer M; Weiand H; Stelkens H; Lucas R; Glänzer K; Witassek F; Stumpe KO; Trübestein G; Krück F
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1729-32. PubMed ID: 1013695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A; Feely J
    Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of aldosterone to mild essential hypertension.
    Zozaya JL; Viloria MP; Castro A
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):471-83. PubMed ID: 6364279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Markers of cardiovascular remodeling in hypertension].
    Legedz L; Rial MO; Lantelme P; Champomier P; Cerutti C; Vincent M; Bricca G; Milon H
    Arch Mal Coeur Vaiss; 2003; 96(7-8):729-33. PubMed ID: 12945212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
    van den Born BJ; Koopmans RP; van Montfrans GA
    Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.